Enzymatica announced that Bengt Baron will assume the role as Executive Chairman of the Board and Therese Filmersson has been appointed acting CEO for the company. Fredrik Lindberg, the company's present CEO, will leave the company in the summer, ­ the recruitment of his successor is ongoing. Fredrik Lindberg, will however, continue to be engaged in the company as he was elected board member at the Annual General Meeting on May 5. As of June 13, Therese Filmersson will assume the role as acting CEO until a new CEO has been recruited while maintaining her role as CFO.

Bengt Baron will act as strategic support to the management as Executive Chairman of the Board. Claus Egstrand will continue in the role as Chief Operating Officer.